$99.1 Million is the total value of DAFNA Capital Management LLC's 59 reported holdings in Q3 2014. The portfolio turnover from Q2 2014 to Q3 2014 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| DSCO | DISCOVERY LABORATORIES INC | $10,486,000 | +3.4% | 5,698,739 | 0.0% | 10.58% | +10.0% | |
| NXTM | NXSTAGE MEDICAL INC | $5,044,000 | -8.6% | 384,154 | 0.0% | 5.09% | -2.8% | |
| PODD | INSULET CORP | $4,032,000 | -7.1% | 109,418 | 0.0% | 4.07% | -1.1% | |
| NVDQ | NOVADAQ TECHNOLOGIES INC | $3,344,000 | -23.0% | 263,541 | 0.0% | 3.37% | -18.1% | |
| DSCI | DERMA SCIENCES INC | $3,205,000 | -27.9% | 384,794 | 0.0% | 3.23% | -23.3% | |
| INSULET CORPnote 2.000% 6/1 | $2,675,000 | 0.0% | 2,407,000 | 0.0% | 2.70% | +6.4% | ||
| CRDC | CARDICA INC | $1,590,000 | -6.1% | 1,486,004 | 0.0% | 1.60% | -0.1% | |
| BEAT | BIOTELEMETRY INC | $1,581,000 | -6.4% | 235,645 | 0.0% | 1.60% | -0.4% | |
| XNPT | XENOPORT INC | $1,292,000 | +11.4% | 240,190 | 0.0% | 1.30% | +18.6% | |
| NUVASIVE INCnote 2.750% 7/0 | $1,146,000 | 0.0% | 1,000,000 | 0.0% | 1.16% | +6.4% | ||
| SPNC | SPECTRANETICS CORP | $1,120,000 | +16.1% | 42,162 | 0.0% | 1.13% | +23.5% | |
| APPY | VENAXIS INC | $1,092,000 | -25.6% | 658,000 | 0.0% | 1.10% | -20.8% | |
| JNJ | JOHNSON AND JOHNSON | $1,002,000 | +1.9% | 9,400 | 0.0% | 1.01% | +8.5% | |
| ECIA | ENCISION INC | $983,000 | -12.7% | 1,062,500 | 0.0% | 0.99% | -7.1% | |
| ELOS | SYNERON MEDICAL LTD | $911,000 | -3.0% | 90,947 | 0.0% | 0.92% | +3.3% | |
| CUTR | CUTERA INC | $896,000 | -2.8% | 88,694 | 0.0% | 0.90% | +3.4% | |
| EXAC | EXACTECH INC | $724,000 | -9.3% | 31,636 | 0.0% | 0.73% | -3.4% | |
| CYTR | CYTRX CORP | $572,000 | -39.2% | 225,000 | 0.0% | 0.58% | -35.3% | |
| ICPT | INTERCEPT PHARMACEUTICALS IN | $473,000 | 0.0% | 2,000 | 0.0% | 0.48% | +6.5% | |
| FATE | FATE THERAPEUTICS INC | $387,000 | -19.2% | 75,930 | 0.0% | 0.39% | -14.1% | |
| MASI | MASIMO CORPORATION | $372,000 | -9.9% | 17,500 | 0.0% | 0.38% | -4.1% | |
| SCYX | SCYNEXIS INC | $370,000 | -7.7% | 50,000 | 0.0% | 0.37% | -1.8% | |
| CLTX | CELSUS THERAPEUTICS PLCsponsored adr ne | $268,000 | -1.5% | 43,900 | 0.0% | 0.27% | +4.7% | |
| BLFS | BIOLIFE SOLUTIONS INC | $244,000 | -7.9% | 116,279 | 0.0% | 0.25% | -2.0% | |
| CRIS | CURIS INC | $212,000 | -24.0% | 150,000 | 0.0% | 0.21% | -18.9% | |
| GNVC | GENVEC INC | $208,000 | -19.1% | 100,000 | 0.0% | 0.21% | -13.9% | |
| CEMI | CHEMBIO DIAGNOSTICS INC | $205,000 | +8.5% | 55,202 | 0.0% | 0.21% | +15.6% | |
| TNXP | TONIX PHARMACEUTICALS HLDG C | $171,000 | -52.4% | 25,000 | 0.0% | 0.17% | -49.4% | |
| RVP | RETRACTABLE TECHNOLOGIES INC | $58,000 | +16.0% | 20,000 | 0.0% | 0.06% | +23.4% |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2014-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| STEREOTAXIS INC | 42 | Q3 2023 | 27.6% |
| ATRICURE INC | 42 | Q3 2023 | 11.4% |
| MASIMO CORPORATION | 42 | Q3 2023 | 1.8% |
| ASCENDIS PHARMA A S SPONSORED | 34 | Q3 2023 | 4.5% |
| AERIE PHARMACEUTICALS INC | 33 | Q3 2022 | 4.2% |
| GALAPAGOS NV-SPON ADR | 33 | Q3 2023 | 3.8% |
| XENON PHARMACEUTICALS INC | 33 | Q3 2023 | 3.6% |
| NEUROCRINE BIOSCIENCES INC | 32 | Q3 2023 | 2.9% |
| JOHNSON AND JOHNSON | 32 | Q1 2021 | 1.2% |
| ISHARES TR NASDQ BIOTECH | 30 | Q3 2023 | 4.0% |
View DAFNA Capital Management LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Stereotaxis, Inc. | March 08, 2018 | 13,680,554 | 23.4% |
| SUNESIS PHARMACEUTICALS INC | February 14, 2018 | 983,000 | 2.9% |
| SUNESIS PHARMACEUTICALS INC | February 14, 2017 | 1,133,583 | 5.4% |
| WINDTREE THERAPEUTICS INC /DE/ | February 14, 2017 | 208,333 | 2.4% |
| ANAVEX LIFE SCIENCES CORP.Sold out | February 16, 2016 | 0 | 0.0% |
| DISCOVERY LABORATORIES INC /DE/ | February 16, 2016 | 10,658,699 | 9.2% |
| PRECISION OPTICS CORPORATION, INC. | February 13, 2015 | 311,537 | 5.0% |
| TearLab Corp | February 14, 2013 | 939,239 | 3.2% |
| VIKING SYSTEMS INC | February 14, 2012 | 3,781,468 | 5.2% |
View DAFNA Capital Management LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| SC 13G/A | 2023-02-14 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
View DAFNA Capital Management LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.